UK study tracks COVID patients, fears long-term symptoms could become common

Fewer than 30 percent of hospitalized patients with COVID-19 (coronavirus disease 2019) have fully recovered following a full year, according to a UK study published in the medical journal Lancet Respiratory Medicine. Research warns that “long COVID” may become a common condition.

COVID-19 pandemic long covid symbol. Medical uniform, white card with words long covid, metalic pen and stethoscope. Medical, COVID-19 pandemic long covid concept.

A British study pointed out that the sequelae of the new coronavirus, “long COVID”, may become a common condition. (Schematic/Getty image)

In the study of more than 2,300 people, women were 33 percent less likely than men to make a full recovery, Agence France-Presse reported. The study also found that people who were obese were only half as likely to make a full recovery; those who were put on a ventilator were 58 percent less likely to make a full recovery.

The study looked at the health of people discharged from 39 UK hospitals between March 2020 and April 2021, and reassessed the recovery of 807 of them at five months and one year. According to the study, only 26% of respondents reported full recovery following five months, and only slightly increased to 28.9% following one year.

Rachel Evans, of the National Institutes of Health Medicine, who co-led the study, said: “During the period from 5 months to 1 year following discharge, patients’ symptoms, mental health status, exercise capacity, organ damage and quality of life were The recovery has been surprisingly limited.”

The most common long-term symptoms of COVID-19 are tiredness, muscle pain, poor sleep, reduced mobility and shortness of breath. Christopher Brightling of the University of Leicester, who also led the study, said: “Without effective treatment, long-term symptoms of Covid-19 might become a highly prevalent long-term condition.” Track patient health.

Editor: Qin Yingwen

global pandemic
UK study tracks COVID-19 patients, fears long-term symptoms may become common
Kexing, Sinopharm can not stop the epidemic Der Spiegel: China is considering the introduction of German BNT
British man dies 505 days following contracting coronavirus
Tokyo epidemic slows down, South Korea opens indoor eating and drinking from tomorrow
The latest data released in Japan… Revealing the third dose of youth protection

Related news video

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.